Sign Up Today and Learn More About Lycia Therapeutics Stock
Invest in or calculate the value of your shares in Lycia Therapeutics or other pre-IPO companies through EquityZen's platform.
Lycia Therapeutics Stock (LYTH)
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
About Lycia Therapeutics Stock
Founded
2019
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
Lycia Therapeutics Management
Leadership team at Lycia Therapeutics
Board Member
Timothy Anderson
Board Member
Clare Ozawa
Join now and verify your accreditation status to gain access to:
- Lycia Therapeutics current valuation
- Lycia Therapeutics stock price
- Available deals in Lycia Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Lycia Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Lycia Therapeutics through EquityZen funds. These investments are made available by existing Lycia Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Lycia Therapeutics stock?
Shareholders can sell their Lycia Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
